Medicine and Dentistry
Ganglioneuroblastoma
100%
Neoplasm
36%
Pediatrics
34%
Liquid Biopsy
26%
Solid Malignant Neoplasm
23%
Wilms' Tumor
17%
Disease
16%
Immunotherapy
16%
Kidney Tumour
15%
Biological Marker
15%
Patient with Neuroblastoma
15%
Cell-Free DNA
13%
Minimal Residual Disease
13%
Childhood Cancer
12%
Diagnosis
12%
(3 Iodobenzyl)guanidine
12%
Messenger RNA
11%
Droplet Digital Polymerase Chain Reaction
10%
Pediatric Cancer
10%
Event Free Survival
9%
Clear Cell Renal Cell Carcinoma
9%
Quantitative Reverse Transcription Polymerase Chain Reaction
9%
Organoid
9%
Catecholamine
8%
Rhabdomyosarcoma
8%
Overall Survival
8%
Neuroblastoma Cell
8%
Malignant Neoplasm
7%
RNA Sequence
6%
Metastatic Carcinoma
6%
Urinary System
6%
Mesenchymal Stem Cell
6%
3-Methoxytyramine
6%
Dinutuximab
5%
Acute Lymphoblastic Leukemia
5%
Positron Emission Tomography-Computed Tomography
5%
Sensitive Detection
5%
Keyphrases
Neuroblastoma
89%
Pediatric Tumors
19%
Liquid Biopsy
18%
High-risk Neuroblastoma
17%
123I-MIBG
15%
Tumor
14%
Bone Marrow
14%
Wilms Tumor
13%
Working Diagnosis
12%
Netherlands
11%
Cell-free DNA (cfDNA)
11%
Pediatric Oncology
10%
RASSF1A
10%
Quantitative PCR
10%
Droplet Digital PCR (ddPCR)
10%
Renal Cell Carcinoma
10%
Minimal Residual Disease
9%
Pediatric
8%
Catecholamines
8%
Event-free Survival
8%
Renal Tumor
8%
Tumors in children
7%
Neuroblastoma Cells
7%
Dinutuximab
7%
Prognostic Biomarker
6%
3-methoxytyramine
6%
Mesenchymal Stromal Cells
6%
Neutrophils
6%
Dutch
5%
Solid Tumors
5%
Rhabdomyosarcoma
5%
Single-cell RNA Sequencing (scRNA-seq)
5%
Extracellular Vesicles
5%
Positron Emission Tomography-computed Tomography (PET-CT)
5%
Patient-specific
5%
Platelets
5%
Pediatric Cancer
5%
RNA Markers
5%
Granulocyte Colony-stimulating Factor (G-CSF)
5%